COMPASS Pathways

NASDAQ: CMPS · Real-Time Price · USD
4.79
0.26 (5.74%)
At close: Jun 06, 2025, 3:59 PM
4.80
0.31%
After-hours: Jun 06, 2025, 05:57 PM EDT

Company Description

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States.

It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder.

The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020.

COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

COMPASS Pathways
COMPASS Pathways logo
Country GB
IPO Date Sep 18, 2020
Industry Medical - Care Facilities
Sector Healthcare
Employees 166
CEO Kabir Kumar Nath M.A., M.B.A.

Contact Details

Address:
33 Broadwick Street
London,
GB
Website https://compasspathways.com

Stock Details

Ticker Symbol CMPS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001816590
CUSIP Number 20451W101
ISIN Number US20451W1018
Employer ID 00-0000000
SIC Code 2834

Key Executives

Name Position
Kabir Kumar Nath M.A., M.B.A. Chief Executive Officer & Director
Anne Benedict Chief People Officer
Dr. Greg Ryslik Ph.D. Chief Technology Officer
Teri Loxam M.B.A. Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer
Dr. Guy Goodwin Chief Medical Officer
Dr. Michael Gold M.D., M.Sc. Chief Research & Development Officer
Dr. Susan C. Stansfield Ph.D. Advisor
Lars Christian Wilde Senior Advisor
Lori Englebert M.B.A. Chief Commercial Officer
Stephen D. Schultz Senior Vice President of Investor Relations

Latest SEC Filings

Date Type Title
May 15, 2025 SCHEDULE 13G/A [Amend] Filing
May 15, 2025 SCHEDULE 13G Filing
May 08, 2025 8-K Current Report
May 08, 2025 10-Q Quarterly Report
May 08, 2025 424B5 Filing
May 07, 2025 SCHEDULE 13G/A [Amend] Filing
Apr 28, 2025 ARS Filing
Apr 28, 2025 DEF 14A Filing
Apr 16, 2025 PRE 14A Filing
Apr 16, 2025 8-K Current Report